- *Improved Digestion*: Domperidone's prokinetic properties enhance gut motility, reducing nausea, vomiting, and discomfort
While technically covered, it won't be approved for your indication
Other important adverse effects to be aware of include: Pancreatitis : If suspected (severe, persistent abdominal pain that may radiate to the back), stop taking Rybelsus immediately and seek urgent medical attention Gallbladder disease : Including gallstones and inflammation of the gallbladder (cholecystitis) Diabetic retinopathy complications : Particularly in patients with pre-existing retinopathy, especially those on insulin Dehydration and acute kidney injury : From persistent vomiting or diarrhoea Whilst there is ongoing surveillance regarding a potential link between GLP-1 receptor agonists and thyroid tumours, there is no established causal relationship in humans, though the medication carries precautionary labelling based on animal studies
In practical terms, that can look like better tolerance for hard training, less of the heavy-leg fatigue that shows up during deficits, and smoother recovery between sessions when everything elseprotein intake, sleep, GLP-1 dosingis aligned
How long are you willing to invest before expecting returns
GLP-1 agonists are also associated with reducing cardiovascular adverse events and MACE by improving ejection fraction, coronary blood flow, and cardiac output.2,3 Tirzepatide (Mounjaro) is a dual receptor agonist for GLP-1 and glucose-dependent insulinotropic polypeptide (GIP)